Aspergillosis of lung
ICD-10 B48.0 is a billable code used to indicate a diagnosis of aspergillosis of lung.
Aspergillosis of the lung is a fungal infection caused by the Aspergillus species, primarily Aspergillus fumigatus. This condition can manifest in various forms, including allergic bronchopulmonary aspergillosis (ABPA), chronic pulmonary aspergillosis, and invasive aspergillosis. Patients with compromised immune systems, such as those with HIV/AIDS, cancer, or those undergoing immunosuppressive therapy, are particularly susceptible to this infection. Symptoms may include cough, hemoptysis, fever, and chest pain. Diagnosis typically involves imaging studies such as chest X-rays or CT scans, along with microbiological cultures or serological tests. Treatment often includes antifungal medications such as voriconazole or amphotericin B, and in some cases, surgical intervention may be necessary to remove infected tissue. The management of aspergillosis requires careful consideration of the patient's immune status and the specific type of aspergillosis present.
Detailed pulmonary function tests and imaging studies must be documented.
Patients presenting with chronic cough, hemoptysis, or recurrent pneumonia.
Consideration of underlying lung diseases such as COPD or asthma.
Comprehensive history of immunosuppression and previous infections.
Patients with a history of organ transplantation or chemotherapy presenting with respiratory symptoms.
Need for thorough documentation of antifungal therapy and response.
Used for treating invasive aspergillosis.
Document the indication for use and patient response.
Pulmonology and Infectious Disease specialists should ensure thorough documentation of treatment plans.
Common symptoms include cough, hemoptysis, fever, chest pain, and difficulty breathing. Symptoms may vary based on the type of aspergillosis.
